Senseonics (NYSEAMERICAN:SENS) will be posting its quarterly earnings results after the market closes on Wednesday, August 7th. Analysts expect Senseonics to post earnings of ($0.16) per share for the quarter. Individual interested in participating in the company’s earnings conference call can do so using this link.
Senseonics (NYSEAMERICAN:SENS) last released its earnings results on Thursday, May 9th. The company reported ($0.17) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.12) by ($0.05). The firm had revenue of $3.42 million during the quarter, compared to the consensus estimate of $4.05 million.
NYSEAMERICAN SENS opened at $1.08 on Tuesday. Senseonics has a one year low of $1.02 and a one year high of $4.89.
Senseonics Company Profile
Senseonics Holdings, Inc, a medical technology company, designs, develops, and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe. Its products include Eversense and Eversense XL, which are implantable CGM systems that is designed to continually and accurately measure glucose levels in people with diabetes for a period of up to 90 and 180 days.
Read More: What is a death cross?
Receive News & Ratings for Senseonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics and related companies with MarketBeat.com's FREE daily email newsletter.